In this second episode of Inside the Author Studio: Behind the Scenes with the Guideline Authors, Dr. Jim Januzzi interviews guideline author Dr. Javed Butler on the efficacy of SGLT2is relative to ejection fraction and the foundational therapies for heart failure and his general strategy for prescribing therapies. Listen as Dr. Butler discusses the guideline recommendation for hospitalization initiation of guideline-directed medical therapy. In addition, Dr. Butler provides his thoughts on using artificial intelligence within the next decade to diagnose, provide treatment strategies, and predict outcomes for heart failure patients.
This podcast is part of the Heart Failure & SGLT2is: The New Pillar in Care grant initiative.
Educational grant support is provided by Boehringer Ingelheim Pharmaceuticals Inc. (BIPI) and Lilly USA, LLC (Lilly). Click here for more: https://learn.acc.org/Page/LearnSGLT2andHF